Aaron Lisberg

10.0k citations
75 papers · 1.9k · 3 hit papers · h-index 18

Impact in

  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • HER2/EGFR in Cancer Research
    • Lung Cancer Research Studies
    • Polyomavirus and related diseases
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Lung Cancer Research Studies 25
    • Cancer Immunotherapy and Biomarkers 21
    • HER2/EGFR in Cancer Research 11
    • Colorectal Cancer Treatments and Studies 4
    • Lung Cancer Treatments and Mutations 31
    • Lung Cancer Diagnosis and Treatment 9

Aaron Lisberg

70 papers receiving 1.9k citations

Aaron Lisberg's Hit Papers

Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study 2024 · 84 citations
840+3+6Years since publication250500750

Peers

Aaron Lisberg
Comparison fields: 5 of 80
  • Oncology 1.3k
  • Pulmonary and Respiratory Medicine 634
  • Radiology, Nuclear Medicine and Imaging 269
  • Immunology 238
  • Cancer Research 117
Replace Rohit Sharma with:
Rohit Sharma United States
Somnath Mukherjee United Kingdom
Youjin Lee United States
Benjamin T. Cooper United States
Gerald B. Fogarty Australia
D. Pectasides Greece
Ferry Lalezari Netherlands
Alessandra Curioni‐Fontecedro Switzerland
M. Drijkoningen Belgium
Jason C. Chandler United States
Aaron Lisberg relative to Rohit Sharma United States Rohit Sharma's profile →
Citations per field
00.5×6.7×
Rohit Sharma · 1×
Citations per year

Countries citing papers authored by Aaron Lisberg

Since Specialization
Citations

This map shows the geographic impact of Aaron Lisberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron Lisberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron Lisberg more than expected).

Fields of papers citing papers by Aaron Lisberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron Lisberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron Lisberg. The network helps show where Aaron Lisberg may publish in the future.

Co-authors

The 25 scholars most cited alongside Aaron Lisberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aaron Lisberg Line = papers co-authored together Aaron Lisberg links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial
Hit paper breakdown →
2017842
2 2016123
3
First-in-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2–Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non–Small-Cell Lung Cancer: TROPION-PanTumor01
Hit paper breakdown →
202393
4
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
Hit paper breakdown →
202484
5 201956
6 202142
7 202339
8 202238
9 202135
10 202435
11 202333
12 202432
13 202129
14 202126
15 202126
16 202123
17 200522
18 202221
19 202317
20 202017

About Aaron Lisberg

Aaron Lisberg is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology, having authored 75 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (31 papers), Lung Cancer Research Studies (25 papers), Cancer Immunotherapy and Biomarkers (21 papers), HER2/EGFR in Cancer Research (11 papers), Lung Cancer Diagnosis and Treatment (9 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Immunotherapy and Immune Responses (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). The work is most often cited by research in Oncology (1.3k citations), Pulmonary and Respiratory Medicine (634 citations), Radiology, Nuclear Medicine and Imaging (269 citations), Immunology (238 citations) and Cancer Research (117 citations). Aaron Lisberg has collaborated with scholars based in United States, Japan and France. Frequent co-authors include Edward B. Garon, Jonathan W. Goldman, Percy Lee, Krikor Bornazyan, Narek Shaverdian, Silvia C. Formenti, Darlene Veruttipong, Jacob Sands, Funda Meric‐Bernstam and Toshio Shimizu. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact